Elicio Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -293 | -290 | -286 |
EBITDA | -6,887 | -11,501 | -8,766 |
EBIT | -7,180 | -11,791 | -9,052 |
Net Income | -7,229 | -11,827 | -8,949 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -12,122 | -12,122 | -9,896 |
Cash | 3,821 | 11,853 | 12,894 |
Basic Shares | 11,284 | 10,273 | 9,603 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $28,312 | $2,880 |
Gross Profit | -1,170 | -1,057 | 27,078 | 1,062 |
EBITDA | -32,966 | -23,554 | -51,925 | -15,527 |
EBIT | -33,348 | -24,611 | -52,726 | -16,155 |
Net Income | -35,195 | -28,207 | -26,400 | -15,712 |
Net Change In Cash | 0 | 0 | 28,312 | 2,880 |
Free Cash Flow | -32,760 | -22,832 | -24,464 | -16,904 |
Cash | 12,894 | 6,155 | 9,278 | 14,967 |
Basic Shares | 5,056 | 3,100 | 3,200 | 8,150 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.39 |
2024-06-30 | -$0.64 |
2024-03-31 | -$1.15 |
2023-12-31 | -$1.75 |
